Asker Healthcare (ASKER) - Net Assets
Based on the latest financial reports, Asker Healthcare (ASKER) has net assets worth Skr6.51 Billion SEK (≈ $700.36 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr15.94 Billion ≈ $1.72 Billion USD) and total liabilities (Skr9.43 Billion ≈ $1.01 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Asker Healthcare total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr6.51 Billion |
| % of Total Assets | 40.84% |
| Annual Growth Rate | 24.37% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 19.63 |
Asker Healthcare - Net Assets Trend (2021–2024)
This chart illustrates how Asker Healthcare's net assets have evolved over time, based on quarterly financial data. Also explore Asker Healthcare asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Asker Healthcare (2021–2024)
The table below shows the annual net assets of Asker Healthcare from 2021 to 2024. For live valuation and market cap data, see ASKER market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr3.50 Billion ≈ $376.87 Million |
+15.16% |
| 2023-12-31 | Skr3.04 Billion ≈ $327.26 Million |
+8.96% |
| 2022-12-31 | Skr2.79 Billion ≈ $300.36 Million |
+53.35% |
| 2021-12-31 | Skr1.82 Billion ≈ $195.86 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Asker Healthcare's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 140.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr1.65 Billion | 47.62% |
| Common Stock | Skr55.00K | 0.00% |
| Other Comprehensive Income | Skr246.00 Million | 7.09% |
| Other Components | Skr1.57 Billion | 45.29% |
| Total Equity | Skr3.47 Billion | 100.00% |
Asker Healthcare Competitors by Market Cap
The table below lists competitors of Asker Healthcare ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Axtel S.A.B. de C.V
MX:AXTELCPO
|
$3.11 Billion |
|
Pingdingshan Tianan Coal Mining Co Ltd
SHG:601666
|
$3.11 Billion |
|
Marathon Digital Holdings Inc
NASDAQ:MARA
|
$3.12 Billion |
|
CRRC Corporation Limited
F:C2L
|
$3.12 Billion |
|
ITI Limited
NSE:ITI
|
$3.11 Billion |
|
Chongqing Water Group Co Ltd
SHG:601158
|
$3.11 Billion |
|
TGS NOPEC Geophysical Company ASA
OL:TGS
|
$3.11 Billion |
|
Bank of Hawaii Corporation
NYSE:BOH
|
$3.11 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Asker Healthcare's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,023,000,000 to 3,469,000,000, a change of 446,000,000 (14.8%).
- Net income of 360,000,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 246,000,000.
- Other factors decreased equity by 160,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr360.00 Million | +10.38% |
| Other Comprehensive Income | Skr246.00 Million | +7.09% |
| Other Changes | Skr-160.00 Million | -4.61% |
| Total Change | Skr- | 14.75% |
Book Value vs Market Value Analysis
This analysis compares Asker Healthcare's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.34x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.16x to 8.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | Skr4.68 | Skr75.55 | x |
| 2022-12-31 | Skr7.21 | Skr75.55 | x |
| 2023-12-31 | Skr7.89 | Skr75.55 | x |
| 2024-12-31 | Skr9.06 | Skr75.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Asker Healthcare utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.38%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.40%
- • Asset Turnover: 1.15x
- • Equity Multiplier: 3.78x
- Recent ROE (10.38%) is below the historical average (14.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 26.07% | 4.99% | 1.27x | 4.11x | Skr287.90 Million |
| 2022 | 15.56% | 3.67% | 1.15x | 3.70x | Skr153.70 Million |
| 2023 | 6.72% | 1.51% | 1.19x | 3.75x | Skr-99.30 Million |
| 2024 | 10.38% | 2.40% | 1.15x | 3.78x | Skr13.10 Million |
Industry Comparison
This section compares Asker Healthcare's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $9,296,000,000
- Average return on equity (ROE) among peers: 0.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Asker Healthcare (ASKER) | Skr6.51 Billion | 26.07% | 1.45x | $3.11 Billion |
| Arjo AB (publ) (ARJO-B) | $9.30 Billion | 0.00% | 0.42x | $662.98 Million |
About Asker Healthcare
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more